ACIU (AC Immune S.A.) Yalpi foyda bo'yicha rentabellik

ACIU (AC Immune S.A.) - kompaniyaning tovar belgisi

AC Immune neyrodegeneratsiyaga qarshi kurashish uchun biofarmatsevtika aniqlik tibbiyoti tizimini ishlab chiqmoqda va himoyalangan patent perimetrini shakllantirmoqda. Valo profit marjalari ishlab chiqarish samaradorligi dinamikasini aks ettiradi, bunda 0.00 joriy parametr qiymati vazifasini bajaradi. Hamkorlarning vaksina ishlab chiqarish quvvatlari uskunalarning yeyilishini qat'iy nazorat qilish ostida reja asosida ishlamoqda. Demensiya diagnostikasi va terapiyasining integratsiyasi neyrobiologiya uchun zarur poydevorni tashkil etadi.

ACIU AC Immune Yalpi foyda bo'yicha rentabellik (04.07.2022 - 19.11.2026)

AC Immune S.A. (ACIU) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:AC Immune
AC Immune SA brendining mahsuloti

Neyrodegenerativ kasalliklar terapiyalariga bo'lgan yuqori talab va AC Immune (ACIU) uchun yangi litsenziyalash shartnomalari biznesning operatsion samaradorligiga bevosita ta'sir ko'rsatadi. Valo daromad marjasi tushumning bevosita ishlab chiqarish xarajatlari chegirib tashlangan qismini o'lchaydi, bu esa investorlarga mahsulotning haqiqiy daromadliligini va kompaniyaning narx belgilash imkoniyatlarini baholash imkonini beradi, bu esa valo daromad marjasi barqarorligining tahlili orqali tasdiqlanadi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)